Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.780
-0.020 (-0.42%)
At close: Mar 18, 2026, 4:00 PM EDT
4.780
0.00 (0.00%)
After-hours: Mar 18, 2026, 4:45 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $309.04 million as of March 18, 2026. Its market cap has increased by 572.49% in one year.
Market Cap
309.04M
Enterprise Value
92.62M
1-Year Change
572.49%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $309.04M, a decrease of -15.53%. That is a compound annual growth rate of -3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 310.33M | -26.96% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 341.44M |
| Climb Bio | 340.59M |
| NovaBridge Biosciences | 334.34M |
| Neurogene | 334.11M |
| Crescent Biopharma | 322.41M |
| AC Immune | 318.55M |
| XOMA Royalty | 316.35M |
| X4 Pharmaceuticals | 311.27M |